Pioneering solutions, saving lives
Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future.
Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.
Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.
| Brain Tumour / Neurosurgery: | NsurgClerk@mh.org.au |
| Dementia: | DementiaTrials@mh.org.au |
| Epilepsy: | EpilepsyCoordinator@mh.org.au |
| Huntington’s Disease: | RMHHuntingtonDiseaseStudies@mh.org.au |
| Movement Disorders: | PDNurse@mh.org.au |
| Multiple Sclerosis: | MSClinic@mh.org.au |
| Neurophysiology: | RMH-ClinicalNeurophysiology@mh.org.au |
| Stroke: | RMH-StrokeResearchTeam@mh.org.au |
| General: | Neuro.Foundation@mh.org.au |
Multiple Sclerosis
Early detection of neurodegeneration in MS
Early detection of neurodegeneration in MS
HREC:
2019.132
Principal Investigator:
Prof Trevor Kilpatrick
Coordinator contact:
Prof Tomas Kalincik
Funding:
Non-Commercial
Prof Trevor Kilpatrick
Multiple Sclerosis
Pregnancy & MS Outcomes
Pregnancy & MS Outcomes
HREC:
2016.385
Principal Investigator:
Prof Tomas Kalincik
Coordinator contact:
Dr Ai-Lan Nguyen
Funding:
Non-Commercial
Prof Tomas Kalincik
Multiple Sclerosis
Genotype-Phenotype correlations in MS
Genotype-Phenotype correlations in MS
HREC:
2013.111
Principal Investigator:
Prof Helmut Butzkueven
Coordinator contact:
A/Prof Vilija Jokubaitis
Funding:
Non-Commercial
Prof Helmut Butzkueven
Multiple Sclerosis
B-cell Repopulation
B-cell repopulation in patients with multiple sclerosis treated with anti-CD20 therapies
HREC:
2023.079
Principal Investigator:
Prof Tomas Kalincik
Coordinator contact:
Funding:
Non-Commercial
Prof Tomas Kalincik
Multiple Sclerosis
SARS-CoV2 antibody-seroprevalence in MS
SARS-CoV2 antibody-seroprevalence in patients with multiple sclerosis
HREC:
2020.305
Principal Investigator:
Dr Chris Dwyer
Coordinator contact:
Funding:
Non-Commercial
Dr Chris Dwyer